HPV vaccines: separating real hope from drug company hype
Kang, G.
Indian Journal of Medical Ethics 7(1): 56-57
2010
ISSN/ISBN: 0974-8466 PMID: 20166306 Document Number: 224125
Document emailed within 1 workday
Related Documents
Janssen, J.J.W.M.; Huijgens, P.C. 2006: Stem cells: hype and hope Nederlands Tijdschrift Voor Geneeskunde 150(27): 1494-1496Simon, D. 1992: Steroids in alcohol hepatitis: hope or hype? American Journal of Gastroenterology 87(12): 1883-1884
Feussner, H.; Wilhelm, D.; Meining, A.; Schneider, A.; Fiolka, A.; Can, S.; Friess, H. 2009: Notes: technical aspects - hype or hope? Surgical Technology International 18: 26-35
Morrow, M. 1998: Primary chemotherapy for breast cancer: hope or hype? Seminars in Oncology 25(2 Suppl 3: 1-2
Lee, J. 2014: Hype or hope for diabetes mobile health applications? Diabetes Research and Clinical Practice 106(2): 390-392
Jacobs, J.W.G.H.; Huizinga, T.W.J.; Bijlsma, J.W.J.H.; van der Helm-van Mil, A.H.M. 2009: Progress due to genetic research on rheumatoid arthritis: hype or hope? Nederlands Tijdschrift Voor Geneeskunde 153: A206
Toh, H.C. 2000: High dose chemotherapy in breast cancer--a thin red line between hype and hope Singapore Medical Journal 41(2): 86-88
Van Rie, A.; Page-Shipp, L.; Scott, L.; Sanne, I.; Stevens, W. 2010: Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Review of Molecular Diagnostics 10(7): 937-946
Mateu, J. 1984: Nouveaux lébiens d'Afrique appartenant aux genres Philorhizus Hope et Syntomus Hope (Coleoptera, Carabidae) - New Lebiidae of the genus Philorhizus Hope et Syntomus Hope Nouv. Rev. Entomol 1(4): 339-346
Jabbour, S.; Nishtar, S.; Prabhakaran, D.; Chockalingam, A.; Achutti, A.; Agrawal, A.; Luna, M.A.; Garofalo, F.; Wielgosz, A. 2003: Information and communication technology in cardiovascular disease prevention in developing countries: hype and hope. Report of the International Collaboration on Information Use in Cardiovascular Health Promotion in Developing Countries International Journal of Cardiology 92(2-3): 105-111
Dryden, M.W.; Carithers, D.; Murray, M.J. 2011: Flea control: real homes, real problems, real answers, real lessons: hitchhiker fleas and the indoor-only cats Compendium 33(6): E4
Pfeil-Doyle, J.L.; Jones, M.D.; Oberlin, J.A.; Benitez, J. 1990: Drug information services at Eli Lilly and Company American Journal of Hospital Pharmacy 47(9): 1996-1998
Luna, D.R.; Rizzato Lede, D.A.; Rubin, L.; Otero, C.M.; Ortiz, J.M.; García, Mónica.G.; Rapisarda, R.P.; Risk, M.R.; González Bernaldo de Quirós, Fán. 2017: User-Centered Design Improves the Usability of Drug-Drug Interaction Alerts: A Validation Study in the Real Scenario Studies in Health Technology and Informatics 245: 1085-1089
Kovac, C. 2001: Drug company breaks 30 year agreement on patient advertising Bmj 323(7311): 470
Tanne, J.Hopkins. 2009: US university psychiatrist loses chairmanship over drug company payments Bmj 338: A3188
Evans, A.E. 1976: Anaconda Company and Chile Copper Company v. Overseas Private Investment Corporation. Case No. 16 10 0071 72 American Journal of International Law 70(1): 135-138
Lazar, E.J.; Banks, D.; Graham, C.; Adams, D.; Rheinstein, P.H.; Gross, M.; Witt, A.M. 1992: Drug company sponsorship of education: the response to the FDA draft concept paper JAMA 268(1): 53-54
Taylor, M. 2004: Alleged improprieties. Trial could affect hospital-drug company relationships Modern Healthcare 34(20): 20-21
Zhu, G.-y. 2006: Hope and challenge of drug-eluting stent Zhonghua Xin Xue Guan Bing Za Zhi 34(11): 961-963
McCarthy, M. 2014: US intends to publish drug company payments to doctors from October despite calls for delay Bmj 349: G5693